Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
Close filters
Filter by:
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
from to

Products from TargetMol

TargetMol

TargetMol, based in Boston, Massachusetts, was founded in 2015 and is a drug screening expert in the life science community. The company offers diverse compound libraries, including FDA-approved libraries, and covers a broad spectrum of small molecule compounds such as inhibitors and agonists as well as recombinant proteins and natural products. TargetMol's products are used by researchers worldwide in areas such as cancer research, neurobiology, inflammation, immunology and metabolism.

More information at: www.targetmol.com

Go to the catalogs of TargetMol

Filter
12254 from 12274 pages
No results were found for the filter!
ZLHQ-5f
ZLHQ-5f

Item number: TGM-T62934-100mg

TargetMol
Description: ZLHQ-5f is a dual inhibitor of CDK2 and Topo I, acting on CDK2/CycA2 (IC50: 0.145 µM). ZLHQ-5f has a good safety profile by blocking the cell cycle of HCT116 cells in S phase and inducing apoptosis. Target: Others
MW: 463.53 D
From 1,440.00€ *
Show details
Review
Anticancer agent 26
Anticancer agent 26

Item number: TGM-T62935-100mg

TargetMol
Description: Anticancer agent 26 is a promising candidate for cancer therapy and deserves further development. Target: Others
MW: 463.57 D
From 1,440.00€ *
Show details
Review
SHR2415
SHR2415

Item number: TGM-T62939-100mg

TargetMol
Description: SHR2415 is a selective, potent, orally active inhibitor of ERK1/2. SHR2415 inhibits ERK1 (IC50: 2.8 nM) and ERK2 (IC50: 5.9 nM). SHR2415 exhibits high potency in Colo205 cells (IC50: 44.6 nM). SHR2415 can be used in cancer research. Target: Others
MW: 463.92 D
From 1,440.00€ *
Show details
Review
ZLWT-37
ZLWT-37

Item number: TGM-T62943-100mg

TargetMol
Description: ZLWT-37 is a potent, orally active inhibitor of CDKs, specifically targeting CDK9 (IC50: 0.002 µM) and CDK2 (IC50: 0.054 µM), and is capable of blocking the cell cycle of HCT116 cells in G2/M phase and inducing apoptosis. Target: Others
MW: 464 D
From 1,440.00€ *
Show details
Review
Dopamine D3 receptor antagonist-2
Dopamine D3 receptor antagonist-2

Item number: TGM-T62946-100mg

TargetMol
Description: Dopamine D3 receptor antagonist-2 is a dopamine D3 receptor-selective compound (Ki=2.16 nM) that exhibits potential therapeutic effects in CNS disorders. Target: Others
MW: 464.38 D
From 1,440.00€ *
Show details
Review
(1R,3S)-THCCA-Asn
(1R,3S)-THCCA-Asn

Item number: TGM-T62949-100mg

TargetMol
Description: (1R,3S)-THCCA-Asn (4j) is a selective inhibitor of thrombin with an IC50 range of 0.07-0.14 µM and exhibits anti-thrombotic effects. Target: Others
MW: 464.47 D
From 1,440.00€ *
Show details
Review
IRAK4-IN-18
IRAK4-IN-18

Item number: TGM-T62950-100mg

TargetMol
Description: IRAK4-IN-18 is a potent inhibitor of interleukin 1 receptor-associated kinase 4 (IRAK4) (IC50: 15 nM). It inhibits LPS-induced IL23 production in THP and DC cells and blocks the development of arthritis in rats, making it useful for studying arthritic diseases. Target: Others
MW: 464.49 D
From 1,440.00€ *
Show details
Review
PARP1-IN-5
PARP1-IN-5

Item number: TGM-T62955-100mg

TargetMol
Description: PARP1-IN-5 is a potent, selective, orally active, low-toxicity PARP-1 inhibitor with an IC50 value of 14.7 nM. PARP1-IN-5 can be used in cancer research. Target: Others
MW: 464.53 D
From 1,440.00€ *
Show details
Review
RORgammat inverse agonist 29
RORgammat inverse agonist 29

Item number: TGM-T62956-100mg

TargetMol
Description: RORgammat inverse agonist 29 is a potent, selective, and orally active compound with an IC50 value of 21 nM. It can be utilized in the study of autoimmune diseases, including skin inflammation and psoriasis. Target: Others
MW: 464.53 D
From 1,440.00€ *
Show details
Review
ZK824859 hydrochloride
ZK824859 hydrochloride

Item number: TGM-T62961-100mg

TargetMol
Description: ZK824859 hydrochloride is a selective, orally active inhibitor of urokinase-type fibrinogen activator (uPA) with IC50 values of 79 nM, 1580 nM and 1330 nM for human uPA, tPA and fibrin, respectively. Target: Others
MW: 464.89 D
From 934.00€ *
Show details
Review
Axl-IN-3
Axl-IN-3

Item number: TGM-T62962-100mg

TargetMol
Description: Axl-IN-3 is a selective, potent and orally active inhibitor of AXL kinase (IC50: 41.5 nM) and has a low inhibitory effect on other kinases. Target: Others
MW: 464.95 D
From 1,440.00€ *
Show details
Review
Anti-inflammatory agent 10
Anti-inflammatory agent 10

Item number: TGM-T62967-100mg

TargetMol
Description: Anti-inflammatory agent 10 is a tilomisole-based benzimidazole-thiazole derivative that is orally active. anti-inflammatory agent 10 is more active against COX-2 enzymes than COX-1. Target: Others
MW: 465.34 D
From 1,440.00€ *
Show details
Review
12254 from 12274 pages
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the usability of this website, serve for direct advertising or simplify interaction with other websites and social networks, will only be used with your consent. More information
Decline Accept all Configure